Ritu Baral
Stock Analyst at TD Cowen
(2.89)
# 1,546
Out of 5,180 analysts
46
Total ratings
37.93%
Success rate
2.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TERN Terns Pharmaceuticals | Downgrades: Hold | $53 | $52.72 | +0.53% | 2 | Mar 26, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $35 → $37 | $22.26 | +66.22% | 3 | Feb 26, 2026 | |
| KRYS Krystal Biotech | Maintains: Buy | $202 → $306 | $258.32 | +18.46% | 1 | Jan 9, 2026 | |
| VTVT vTv Therapeutics | Initiates: Buy | $67 | $40.37 | +65.96% | 1 | Jan 5, 2026 | |
| INSM Insmed | Maintains: Buy | $269 → $241 | $163.52 | +47.38% | 7 | Dec 18, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $97 → $133 | $124.65 | +6.70% | 3 | Dec 16, 2025 | |
| MIST Milestone Pharmaceuticals | Upgrades: Buy | $8 | $1.19 | +572.27% | 1 | Dec 15, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $251 → $353 | $322.19 | +9.56% | 1 | Dec 8, 2025 | |
| VERA Vera Therapeutics | Maintains: Buy | $60 → $73 | $40.23 | +81.46% | 2 | Dec 5, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $390 → $554 | $523.47 | +5.83% | 2 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.34 | - | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.42 | - | 2 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $282 → $371 | $330.87 | +12.13% | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.23 | - | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $175 | $21.76 | +704.23% | 1 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $65.35 | - | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $8.97 | - | 1 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $14.06 | - | 1 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.54 | - | 2 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.26 | - | 1 | Jun 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.37 | - | 2 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $424.69 | - | 2 | Jan 12, 2018 |
Terns Pharmaceuticals
Mar 26, 2026
Downgrades: Hold
Price Target: $53
Current: $52.72
Upside: +0.53%
ACADIA Pharmaceuticals
Feb 26, 2026
Maintains: Buy
Price Target: $35 → $37
Current: $22.26
Upside: +66.22%
Krystal Biotech
Jan 9, 2026
Maintains: Buy
Price Target: $202 → $306
Current: $258.32
Upside: +18.46%
vTv Therapeutics
Jan 5, 2026
Initiates: Buy
Price Target: $67
Current: $40.37
Upside: +65.96%
Insmed
Dec 18, 2025
Maintains: Buy
Price Target: $269 → $241
Current: $163.52
Upside: +47.38%
Palvella Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $97 → $133
Current: $124.65
Upside: +6.70%
Milestone Pharmaceuticals
Dec 15, 2025
Upgrades: Buy
Price Target: $8
Current: $1.19
Upside: +572.27%
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $251 → $353
Current: $322.19
Upside: +9.56%
Vera Therapeutics
Dec 5, 2025
Maintains: Buy
Price Target: $60 → $73
Current: $40.23
Upside: +81.46%
Madrigal Pharmaceuticals
Aug 26, 2025
Maintains: Buy
Price Target: $390 → $554
Current: $523.47
Upside: +5.83%
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.34
Upside: -
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $3.42
Upside: -
Oct 21, 2024
Maintains: Buy
Price Target: $282 → $371
Current: $330.87
Upside: +12.13%
Aug 8, 2023
Initiates: Outperform
Price Target: n/a
Current: $5.23
Upside: -
Mar 22, 2023
Maintains: Outperform
Price Target: $125 → $175
Current: $21.76
Upside: +704.23%
Nov 23, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $65.35
Upside: -
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $8.97
Upside: -
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $14.06
Upside: -
Jul 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.54
Upside: -
Jun 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.26
Upside: -
Jul 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $0.37
Upside: -
Jan 12, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $424.69
Upside: -